Main Page Winners Spain: Winners

Pharmaceutical products (№2803136)

16 sep

Number: 2803136

Country: Spain

Source: TED

PUSH for registration

Share:

Link to original

To view links to the source need to register

Publication date


16-09-2017

Description


  1. Section I
    1. Name and addresses
      Osakidetza
      c/ Álava, 45
      Vitoria-Gasteiz
      01006
      Spain
      Telephone: +34 945006317
      E-mail: [email protected]
      Fax: +34 945006345
    2. Type of the contracting authority:
      Other type: ente público de derecho privado
    3. Main activity:
      Health
  2. Section II
    1. Scope of the procurement:
      1. Title:

        Suministro del medicamento inhibidor de C1 derivado del plasma (DOE) para todas las organizaciones de servicios de Osakidetza.


        Reference number: G/100/20/1/0766/OSC1/0000/032017
      2. Main CPV code:
        33600000, 33600000, 33600000
      3. Type of contract:
        Supplies
      4. Short description:

        Suministro del medicamento inhibidor de C1 derivado del plasma (DOE).


      5. Information about lots:
        This contract is divided into lots: yes
      6. Total value of the procurement:
        Value excluding VAT: 2 013 586.25 EUR
    2. Description
      1. Title:

        Inhibidor de C1 derivado del plasma (DOE) en envase de 2 viales de 500 u para tratamiento y prevención preoperatoria de las crisis de angioedema y prevención rutinaria de las crisis de angioedema


      2. Additional CPV code(s):
        33600000
      3. Place of performance:
      4. Description of the procurement:

        Inhibidor de C1 derivado del plasma (DOE) en envase de 2 viales de 500 u para tratamiento y prevención preoperatoria de las crisis de angioedema y prevención rutinaria de las crisis de angioedema.


      5. Award criteria:
        Quality criterion - Name: Criterios sobre calidad y seguridad del medicamento / Weighting: 37
        Quality criterion - Name: Criterios sobre documentación aportada / Weighting: 3
        Cost criterion - Weighting: 55
        Cost criterion - Weighting: 2
        Cost criterion - Weighting: 1
        Cost criterion - Weighting: 2
      6. Information about options:
        Options: yesDescription of options:

        El plazo de vigencia del acuerdo marco podrá ser prorrogado. El número de prórrogas posibles será de una, por plazo de 12 meses y por un importe de 647 500 EUR IVA excluido, por lo que el periodo máximo de duración del acuerdo marco podrá ser de 48 meses incluida la prórroga.


      7. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      8. Additional information:
      9. Title:

        Inhibidor de C1 derivado del plasma (DOE) en envase de 1 vial de 500 ui y en envase de 1 vial de 1 500 UI para tratamiento y prevención preoperatoria de episodios agudos


      10. Additional CPV code(s):
        33600000
      11. Place of performance:
      12. Description of the procurement:

        Inhibidor de C1 derivado del plasma (DOE) en envase de 1 vial de 500 UI y en envase de 1 vial de 1 500 UI para tratamiento y prevención preoperatoria de episodios agudos.


      13. Award criteria:
        Quality criterion - Name: Criterios sobre calidad y seguridad del medicamento / Weighting: 37
        Quality criterion - Name: Criterios sobre documentación aportada / Weighting: 3
        Cost criterion - Weighting: 55
        Cost criterion - Weighting: 2
        Cost criterion - Weighting: 1
        Cost criterion - Weighting: 2
      14. Information about options:
        Options: yesDescription of options:

        El plazo de vigencia del acuerdo marco podrá ser prorrogado. El número de prórrogas posibles será de una, por plazo de 12 meses y por un importe de 647 500 EUR IVA excluido, por lo que el periodo máximo de duración del acuerdo marco podrá ser de 48 meses incluida la prórroga.


      15. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      16. Additional information:
  3. Section IV
    1. Description:
      1. Type of procedure:
        Open procedure
      2. Information about a framework agreement or a dynamic purchasing system:
        The procurement involves the establishment of a framework agreement
      3. Information about electronic auction:
      4. Information about the Government Procurement Agreement (GPA):
        The procurement is covered by the Government Procurement Agreement: yes
    2. Administrative information:
      1. Previous publication concerning this procedure:
        Notice number in the OJ S: 2017/S 060-111601
      2. Information about termination of dynamic purchasing system:
      3. Information about termination of call for competition in the form of a prior information notice:
  4. Section V
    1. Contract No: 1
      Lot No: 1
      Title:

      Inhibidor de C1 derivado del plasma (DOE) en envase de 2 viales de 500 UI


    2. Award of contract
      1. Date of conclusion of the contract: 2017-08-01
      2. Information about tenders:
        Number of tenders received: 2
        The contract has been awarded to a group of economic operators: no
      3. Name and address of the contractor:
        Shire Pharmaceuticals Ibérica, S.L.
        Madrid
        Finland
        The contractor is an SME: no
      4. Information on value of the contract/lot (excluding VAT):

        Total value of the contract/lot: 1 942 500.00 EUR
      5. Information about subcontracting:

        Contract No: 2
        Lot No: 2
        Title:

        Inhibidor de C1 derivado del plasma (DOE) en envase de 1 vial de 500 UI y en envase de 1 vial de 1 500 UI para tratamiento y prevención preoperatoria de episodios agudos


      6. Award of contract
        1. Date of conclusion of the contract: 2017-08-01
        2. Information about tenders:
          Number of tenders received: 1
          The contract has been awarded to a group of economic operators: no
        3. Name and address of the contractor:
          Csl Behring, S.A.
          Barcelona
          Spain
          The contractor is an SME: no
        4. Information on value of the contract/lot (excluding VAT):

          Total value of the contract/lot: 71 086.25 EUR
        5. Information about subcontracting:

    3. Section VI
      1. Additional information
      2. Procedures for review
        1. Review body
          Órgano de Contratación de Osakidetza
          c/ Álava, 45
          Vitoria-Gasteiz
          01006
          Spain
          Telephone: +34 945006152
          E-mail: [email protected]
          Fax: +34 945006345
        2. Body responsible for mediation procedures

        3. Service from which information about the review procedure may be obtained
          Dirección General-Subdirección de Compras, Obras y Servicios Estratégicos
          c/ Álava, 45
          Vitoria-Gasteiz
          01006
          Spain
          Telephone: +34 945006152
          E-mail: [email protected]
          Fax: +34 945006345
      3. Date of dispatch of this notice
        2017-09-14